Brief: Piramal Pharma, Newamsterdam Pharma Invest To Enhance Oral Solid Dosage Capabilities
21/08/2025 14:51
Aug 21 (Reuters) - Piramal Pharma Ltd PIRM.NS: PIRAMAL PHARMA LTD - CO, NEWAMSTERDAM PHARMA INVEST TO ENHANCE ORAL SOLID DOSAGE CAPABILITIES PIRAMAL PHARMA LTD - INVESTMENT EXPECTED TO CREATE MORE THAN 20 NEW JOBS AT SELLERSVILLE SITE Source text: ID:nBSEbp5P1k Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington